Filing Details
- Accession Number:
- 0001209191-21-067892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 17:10:39
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-12-03 17:10:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-01 | 15 | $2.67 | 14,003 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-02 | 15 | $2.63 | 14,018 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-03 | 15 | $2.71 | 14,033 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-04 | 15 | $2.73 | 14,048 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-05 | 15 | $2.71 | 14,063 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-08 | 15 | $2.95 | 14,078 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-09 | 15 | $3.21 | 14,093 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-10 | 15 | $2.94 | 14,108 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-11 | 15 | $2.83 | 14,123 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-12 | 15 | $2.67 | 14,138 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-15 | 15 | $2.71 | 14,153 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-16 | 15 | $2.66 | 14,168 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-17 | 15 | $2.58 | 14,183 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-18 | 15 | $2.58 | 14,198 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-19 | 15 | $2.55 | 14,213 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-22 | 15 | $2.35 | 14,228 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-23 | 15 | $2.29 | 14,243 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-24 | 35 | $2.31 | 14,278 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-26 | 35 | $2.26 | 14,313 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-29 | 35 | $2.23 | 14,348 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-11-30 | 35 | $4.61 | 14,383 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.